Enoxacin for type III A prostatitis: a clinical observation.
- Author:
Zhong CHEN
1
;
Xi-cai ZHOU
;
Zhi-qiang CHEN
;
Zhang-qun YE
;
Rong-jin DENG
Author Information
- Publication Type:Clinical Trial
- MeSH: Adult; Anti-Infective Agents; therapeutic use; Chronic Disease; Enoxacin; therapeutic use; Humans; Male; Middle Aged; Prostatitis; drug therapy; Treatment Outcome; Young Adult
- From: National Journal of Andrology 2010;16(3):258-260
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVEChronic prostatitis, especially type III A, is a common disease in adult males, for which there are quite a few therapeutic methods. This study aimed to investigate the clinical efficacy of enoxacin in the treatment of III A prostatitis.
METHODSWe selected 198 cases of III A prostatitis with complete treatment and follow-up data from the outpatients, all treated by enoxacin injection for 1 week, followed by oral medication of enoxacin for 2 weeks. Then we evaluated the therapeutic effect based on the NIH-CPSI scores and changes in the indexes of expressed prostatic secretions (EPS).
RESULTSThe rate of total effectiveness was 86.4%, cure 8.6% (17/198), remarkable effectiveness 58.1% (115/198), improvement 19.7% (39/198), and ineffectiveness 13.6% (27/198). Only 16 cases (8.1%) complained of transitory gastrointestinal tract discomfort and/or skin itching.
CONCLUSIONEnoxacin has desirable efficacy and few adverse effects on type III A prostatitis.
